Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for MAVENCLAD
- Venetoclax-Navitoclax With Cladribine-based Salvage Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Effects of Oral Cladribine on Remyelination and Inflammation in Multiple Sclerosis Patients
- Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension)
- Cognition and HRQoL in Adults With Highly-active RMS in Year 3 and 4 After Initial Mavenclad® Dose (CLARIFY MS Extension)
- ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis
- A Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine Tablets
- Cladribine Tablets After Treatment With Natalizumab (CLADRINA)
- Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)
- Lintuzumab-Ac225 in Combination With Cladribine + Cytarabine + Filgastrim + Mitoxantrone (CLAG-M) for Relapsed/Refractory Acute Myeloid Leukemia
- Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS)
- Evaluation of the Onset of Action in Highly Active MS (MAGNIFY)
- Efficacy and Pharmacogenomics of Salvage CLAG-M Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia
Clinical trials list
click for details